Is hepatitis C direct-acting antiviral therapy a risk factor for the development and recurrence of hepatocellular carcinoma? Narrative literature review and clinical practice recommendations Carolina Delgado Martínez; Mariano Gómez-Rubio; Cecilia Gómez-Domínguez;

Surveillance and management of hepatocellular carcinoma after treatment of hepatitis C with direct-acting antiviral drugs Caiyun Yang; Fengxiang Lv; Jiaqi Yang; Dawei Ding; Lina Cui; Ying Han;

The influence of hepatitis C virus eradication on hepatocarcinogenesis in patients with hemophiliaHCC after HCV eradication in hemophilia Yosuke Inukai; Norihiro Imai; Kenta Yamamoto; Takanori Ito; Yoji Ishizu; Takashi Honda; Shuichi Okamoto; Takeshi Kanematsu; Nobuaki Suzuki; Tadashi Matsushita; Masatoshi Ishigami; Mitsuhiro Fujishiro;